In a landmark moment for the treatment of pancreatic cancer, the FDA has approved a drug that extends patients' lives https://t.co/LsDCp3y1JO ...

The FDA has approved a new medication for pancreatic cancer patients called daraxonrasib, a once-daily pill that blocks RAS proteins and has been shown to double patient survival time when compared to standard chemotherapy treatment.Read more: https://t.co/Em6Pb1TqRi📸: Sarah Silbiger via Getty Images ...

FDA Approves Pancreatic Cancer Drug That Could Double Survival Timehttps://t.co/eAkCos8djH https://t.co/QFFWKgdkkn ...

Breaking: In a landmark moment for the treatment of pancreatic cancer, the FDA has approved a drug that extends patients' lives https://t.co/usdKcVROBW ...